Pseudoprogression successfully treated with bevacizumab in a child with spinal pilocytic astrocytoma

Kenji Miyata, Toshinori Hori, Yasuto Shimomura, Masahiro Joko, Masakazu Takayasu, Akihisa Okumura

研究成果: ジャーナルへの寄稿学術論文査読

6 被引用数 (Scopus)

抄録

Clinical case: We report on a 7-year-old female with spinal pilocytic astrocytoma complicated by pseudoprogression 1 month after completion of radiation therapy. Although she was initially treated with high-dose steroids, her clinical symptoms did not completely resolve, and magnetic resonance imaging (MRI) revealed extension of the lesions into the medulla oblongata. Treatment with bevacizumab was commenced, followed by rapid resolution of the clinical symptoms and improvements in the MRI findings. Conclusion: This case highlights the efficacy and tolerability of bevacizumab for the treatment of pseudoprogression in children with spinal low-grade gliomas.

本文言語英語
ページ(範囲)2305-2308
ページ数4
ジャーナルChild's Nervous System
34
11
DOI
出版ステータス出版済み - 01-11-2018
外部発表はい

All Science Journal Classification (ASJC) codes

  • 小児科学、周産期医学および子どもの健康
  • 臨床神経学

フィンガープリント

「Pseudoprogression successfully treated with bevacizumab in a child with spinal pilocytic astrocytoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル